Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.03
+0.15 (1.52%)
Jun 26, 2026, 1:15 PM EDT - Market open
Vir Biotechnology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $23 → $27 | Buy | Reiterates | $23 → $27 | +169.19% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +99.40% | Jun 4, 2026 |
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +199.10% | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $16 | Buy | Maintains | $16 | +59.52% | May 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 27, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $18 | Buy | Maintains | $18 | +79.46% | May 7, 2026 |
| Needham | Needham | Buy Maintains $18 | Buy | Maintains | $18 | +79.46% | May 7, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $21 | Buy | Maintains | $21 | +109.37% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.